Renal function and thromboprophylaxis in critically ill patients
- PMID: 20497594
- PMCID: PMC2911697
- DOI: 10.1186/cc8985
Renal function and thromboprophylaxis in critically ill patients
Comment on
-
Enoxaparin, effective dosage for intensive care patients: double-blinded, randomised clinical trial.Crit Care. 2010;14(2):R41. doi: 10.1186/cc8924. Epub 2010 Mar 18. Crit Care. 2010. PMID: 20298591 Free PMC article. Clinical Trial.
References
-
- Douketis J, Cook D, Meade M, Guyatt G, Geerts W, Skrobik Y, Albert M, Granton J, Hebert P, Pagliarello G, Marshall J, Fowler R, Freitag A, Rabbat C, Anderson D, Zytaruk N, Heels-Ansdell D, Crowther M. Canadian critical care trials group. Prophylaxis against deep vein thrombosis in critically ill patients with severe renal insufficiency with low molecular weight heparin dalteparin; An assessment of safety and pharmacodynamics: The DIRECT study. Arch Intern Med. 2008;168:1805–1812. doi: 10.1001/archinte.168.16.1805. - DOI - PubMed
-
- Mahe I, Aghassarian M, Drouet L, Bal Dit-Sollier C, Lacut K, Heilmann JJ, Mottier D, Bergmann JF. Tinzaparin and enoxaparin given at prophylactic dose for eight days in medical elderly patients with impaired renal function: a comparative pharmacokinetic study. Thromb Haemost. 2007;97:581–586. - PubMed
-
- Fuster-Lluch O, Geronimo-Pardo M, Peyro-Garcia R, Lizan-Garcia M. Glomerular hyperfiltration and albuminuria in critically ill patients. Anaesth Intensive Care. 2008;36:674–680. - PubMed
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical